Showing 17,901 - 17,920 results of 29,925 for search '(( 10 ((ng decrease) OR (teer decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.99s Refine Results
  1. 17901

    Pheromone-responding ORNs and MGC calcium responses in virgin and mated males. by Nina Deisig (178118)

    Published 2012
    “…<p><b>A</b>) Typical single sensillum recordings showing an olfactory receptor neuron (ORN) excitatory response to the pheromone (10 ng), no response to heptanal (100 µg) and a reduced response to the pheromone/heptanal mixture in a virgin male. …”
  2. 17902
  3. 17903
  4. 17904
  5. 17905
  6. 17906
  7. 17907
  8. 17908

    Standardized mean effect differences between wet-lab experiment and model simulations. by Rachael Miller Neilan (10678614)

    Published 2021
    “…Positive Hedges’ <i>g</i> is indicative of an increase in pain-like effect for the indicated comparison and a negative Hedges’ <i>g</i> is indicative of a decrease in pain-like effects. …”
  9. 17909
  10. 17910

    BPLF1 selectively inhibits the detection of TOP2-induced DNA damage. by Jinlin Li (2267896)

    Published 2021
    “…The expression of catalytically active BPLF1 was associated with a significant decrease of Etoposide induced nuclear γH2AX fluorescence and decreased formation of 53BP1 foci. …”
  11. 17911
  12. 17912
  13. 17913
  14. 17914
  15. 17915
  16. 17916

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  17. 17917
  18. 17918

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  19. 17919
  20. 17920